The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Histone deacetylase inhibitors in cancer therapy
Author(s): 
Pages: 424-427
Year: Issue:  6
Journal: Journal of International Oncology

Keyword:  NeoplasmsHistone deacetylasesBiological markers;
Abstract: 组蛋白的乙酰化状态调控DNA转录从而影响基因的表达水平.组蛋白脱乙酰基酶(HDAC)可降低组蛋白乙酰化,引起DNA-组蛋白复合物压缩.这种压缩可以阻碍基因转录,抑制细胞分化.HDAC抑制剂可以解除DNA-组蛋白复合物压缩,从而促进肿瘤细胞生长停滞、分化及凋亡.在此过程中,HDAC抑制剂也影响非组蛋白的乙酰化状态和功能.HDAC抑制剂在多种肿瘤中不仅单独使用具有显著的抗肿瘤效应,在联合应用中也具有重...
Related Articles
loading...